CD44 and arthritic joint disease: To our knowledge this is the first study which has examined IM7, KM201, KM114, KM81, 5035-41.1D, and IRAWB14.4 in the same model, and we have shown that all of these CD44 antibodies delayed the onset and reduced the clinical severity of arthritis in this model.